[60] developed a two‐step enrichment protocol using EasySepTM human CD45 depletion kit followed by spheroid culture to isolate both epithelial and/or mesenchymal CTCs and cultured these with a success rate of 46% in blood samples of 13 head and neck cancer patients. The gene discussed is PTPRC; the disease is head and neck cancer.